Antimicrobial-resistant ESKAPE (E nterococcus faecium, S taphylococcus aureus, K
lebsiella pneumoniae, A cinetobacter baumannii, P seudomonas aeruginosa, and E …

Strains of bacteria resistant to antibiotics, particularly those that are multiresistant, are an
increasing major health care problem around the world. It is now abundantly clear that both …

The infection caused by methicillin-resistant Staphylococcus aureus (MRSA) is a global
threat to public health. Vancomycin remains one of the first-line drugs for the treatment of …

The evolution of Staphylococcus aureus during the modern antibiotic era has been
delineated by distinct strain emergence events, many of which include acquisition of …

The use of antibiotics in agriculture is routinely described as a major contributor to the
clinical problem of resistant disease in human medicine. While a link is plausible, there are …

With the advent of the antibiotic era, the overuse and inappropriate consumption and
application of antibiotics have driven the rapid emergence of multidrug-resistant pathogens …

Staphylococcus aureus is a major human and veterinary pathogen worldwide. Methicillin-
resistant S. aureus (MRSA) poses a significant and enduring problem to the treatment of …

Vancomycin is a glycopeptide antibiotic used for the treatment of Gram-positive bacterial
infections. Traditionally, it has been used as a drug of last resort; however, clinical isolates of …

Implant-related infections caused by drug-resistant bacteria remain a major challenge faced
by orthopedic surgeons. Furthermore, ideal prevention and treatment methods are lacking in …

Enterococcus faecium, natively a gut commensal organism, emerged as a leading cause of
multidrug-resistant hospital-acquired infection in the 1980s. As the living record of its …